Filtros de búsqueda

Lista de obras de

'Don't delay, start today': delaying levodopa does not delay motor complications

artículo científico publicado en 2014

5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA.

artículo científico publicado en 2010

5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders

artículo científico publicado en 2013

A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease

artículo científico publicado en 2004

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

artículo científico publicado en 2008

A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating Scale

artículo científico

A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease

artículo científico publicado en 2005

A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease

artículo científico publicado en 2005

Advances in the delivery of treatments for Parkinson's disease

artículo científico publicado en 2005

Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+,K+-ATPase α3 missense mutant mice

artículo científico publicado en 2013

Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?

artículo científico publicado en 2011

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial

artículo científico

Automated assessment of levodopa-induced dyskinesia: Evaluating the responsiveness of video-based features

Automated vision-based analysis of levodopa-induced dyskinesia with deep learning

artículo científico publicado en 2017

Bilateral pallidal stimulation for Wilson's disease

artículo científico publicado en 2013

Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease

artículo científico publicado en 2018

Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism

artículo científico publicado en 2016

Clinical and demographic characteristics related to onset site and spread of cervical dystonia

artículo científico publicado en 2016

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic

artículo científico

Clinical spectrum of levodopa-induced complications

artículo científico publicado en 2014

Clinimetric testing of the comprehensive cervical dystonia rating scale

artículo científico publicado en 2016

Complex genetics of Tourette's Syndrome: Piecing the puzzle

artículo científico publicado en 2017

DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease

artículo científico publicado en 2017

Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology

artículo científico publicado en 2015

Dihydropyridine calcium channel blockers and the progression of parkinsonism

artículo científico publicado en 2012

Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical Trials

artículo científico publicado en 2016

Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease.

artículo científico publicado en 2006

Drug treatments for the neuropsychiatric complications of Parkinson's disease

artículo científico

Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease

scholarly article by Sean J Udow et al published 27 November 2017 in Movement disorders clinical practice

Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease

artículo científico publicado en 2010

Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and Dystonia

artículo científico publicado en 2016

Emerging drugs for levodopa-induced dyskinesia

artículo científico publicado en 2014

Emotion Detection Deficits and Decreased Empathy in Patients with Alzheimer's Disease and Parkinson's Disease Affect Caregiver Mood and Burden.

artículo científico publicado en 2018

Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease

artículo científico publicado en 2018

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease

artículo científico publicado en 2007

Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease

artículo científico publicado en 2010

Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

artículo científico publicado en 2003

Helicobacter pylori infection is associated with worse severity of Parkinson's disease

artículo científico publicado en 2014

Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease

artículo científico publicado en 2006

Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease

artículo científico publicado en 2013

Improvement of apathy after levofloxacin treatment: an N-of-1 study

artículo científico publicado en 2012

Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations

artículo científico publicado en 2010

Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease

artículo científico publicado en 2012

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease

artículo científico publicado en 2003

Integrating Patient Concerns into Parkinson's Disease Management

artículo científico publicado en 2017

International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.

artículo científico publicado en 2018

Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of neurodegenerative disease management

Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of neurodegenerative disease management

L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease

artículo científico publicado en 2012

L-745,870 reduces the expression of abnormal involuntary movements in the 6-OHDA-lesioned rat.

artículo científico publicado en 2015

L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease

artículo científico publicado en 2012

Levodopa-related motor complications--phenomenology

artículo científico publicado en 2008

Measuring mild cognitive impairment in patients with Parkinson's disease

artículo científico publicado en 2013

Medication-related impulse control and repetitive behaviors in Parkinson disease

artículo científico publicado en 2007

Monoamine reuptake inhibitors in Parkinson's disease

artículo científico publicado en 2015

Motor Complications of Dopaminergic Medications in Parkinson's Disease.

artículo científico publicado en 2017

Mutation analysis of CHCHD10 in different neurodegenerative diseases

artículo científico publicado en 2015

Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome

artículo científico publicado en 2008

New insights into the organization of the basal ganglia

artículo científico publicado en 2009

New methods of preventing neurodegeneration? Lessons from prion diseases

artículo científico publicado en 2013

New treatments for the motor symptoms of Parkinson's disease

artículo científico publicado en 2014

Non-dopaminergic treatments for motor control in Parkinson's disease

artículo científico

Non-dopaminergic treatments in development for Parkinson's disease

artículo científico publicado en 2008

Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease

artículo científico publicado en 2004

Novel Levodopa Formulations for Parkinson's Disease

artículo científico publicado en 2016

Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials

artículo científico

Overview of the extranigral aspects of Parkinson disease

artículo científico publicado en 2009

Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy

artículo científico publicado en 2008

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

artículo científico

Pimavanserin as treatment for Parkinson's disease psychosis

artículo científico publicado en 2013

Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: results of a pilot study.

artículo científico publicado en 2015

Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD.

artículo científico publicado en 2015

Psychiatric comorbidities in dystonia: emerging concepts

artículo científico publicado en 2013

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management

artículo científico publicado en 2016

Pure cerebello-olivary degeneration of Marie, Foix, and Alajouanine presenting with progressive cerebellar ataxia, cognitive decline, and chorea

artículo científico publicado en 2003

RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study

artículo científico publicado en 2012

Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia

artículo científico publicado en 2002

Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease

artículo científico publicado en 2010

Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.

artículo científico publicado en 2015

Serotonergic Approaches in Parkinson's Disease: Translational Perspectives, an Update

artículo científico publicado en 2017

Serotonin 2A receptors and visual hallucinations in Parkinson disease

artículo científico publicado en 2010

Serotonin and Parkinson's disease: On movement, mood, and madness

artículo científico publicado en 2009

Small intestinal bacterial overgrowth in Parkinson's disease

artículo científico publicado en 2014

Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease

artículo científico publicado en 2002

Striatal histone modifications in models of levodopa-induced dyskinesia

artículo científico publicado en 2008

Subthalamic nucleus and striatum: the red and green signals to regulate the traffic of basal ganglia circuitry

artículo científico publicado en 2013

Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation

artículo científico publicado en 2010

Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates

artículo científico publicado en 2015

TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque

artículo científico publicado en 2013

Th17 lymphocyte spearheads the immune attack in Parkinson's disease: New evidence for neuronal death

article

The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future

artículo científico publicado en 2010

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

artículo científico

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

artículo científico publicado en 2011

The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques

artículo científico publicado en 2013

The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque.

artículo científico publicado en 2015

The long-term outcome of orthostatic tremor

artículo científico publicado en 2015

The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease

artículo científico publicado en 2012

The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson's disease

artículo científico publicado en 2008

The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease

artículo científico

The pill questionnaire in a nondemented Parkinson's disease population

artículo científico publicado en 2012

The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease

artículo científico publicado en 2011

The serotonergic system in Parkinson's disease

artículo científico publicado en 2011

The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates

artículo científico publicado en 2010

Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure

artículo científico publicado en 2006

Treating the Motor Symptoms of Parkinson Disease

artículo científico publicado en 2016

Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease

artículo científico publicado en 2014

Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease

artículo científico publicado en 2017

Understanding conversion disorders: back to Freud's theory

artículo científico publicado en 2014

Update in therapeutic strategies for Parkinson's disease.

artículo científico publicado en 2018

Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque

artículo científico publicado en 2013

Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias

artículo científico publicado en 2014

Viewpoint: Developing drugs for levodopa-induced dyskinesia in PD: Lessons learnt, what does the future hold?

artículo científico publicado en 2018

Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation

scholarly article by Michael H Li et al published 6 November 2018 in Journal of NeuroEngineering and Rehabilitation

Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting

artículo científico publicado en 2012

l-Dopa-induced dyskinesia-clinical presentation, genetics, and treatment

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda